Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Placebo Effect01:54

The Placebo Effect

6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Blind Procedures02:07

Blind Procedures

10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
Classical Conditioning in Daily Life01:17

Classical Conditioning in Daily Life

860
Classical conditioning, a fundamental principle of associative learning, explains various phenomena observed in daily life, such as fear development, the placebo effect, taste aversion, and drug habituation. These applications demonstrate the profound impact of associative learning on human behavior and physiological responses.
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
860
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

211
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
211
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

190
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
190
Purposive Learning01:22

Purposive Learning

146
E. C. Tolman emphasized the purposiveness of behavior — the idea that much of our behavior is goal-directed. For instance, employees who aim for a promotion work diligently to meet their targets. Tolman argued that when classical conditioning and operant conditioning occur, the organism acquires certain expectations. In classical conditioning, a child might fear a dog because they expect it to bite. In operant conditioning, a person might consistently work overtime because they expect a...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment.

Psychopharmacology·2026
Same author

Evaluating the evidence for repressed memory recovery in psychedelic contexts.

Psychopharmacology·2026
Same author

Brain-body integromics of the ayahuasca experience.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use.

Molecular psychiatry·2026
Same author

An international mega-analysis of psychedelic drug effects on brain circuit function.

Nature medicine·2026
Same author

<i>In Vivo</i> Detection of Nitrous Oxide in Blood and Saliva Following Recreational Use.

ACS omega·2026
Same journal

Effects of antidepressants, anesthetics and sedatives/hypnotics on sleep-associated memory consolidation - A systematic review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mental resilience is not meaningfully associated with the frequency and severity of alcohol hangover.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mitochondrial dysfunction in schizophrenia and its modulation by atypical antipsychotic drugs: A randomized controlled trial.

Journal of psychopharmacology (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 24, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.3K

Harnessing placebo: Lessons from psychedelic science.

Chloé Pronovost-Morgan1,2, Ido Hartogsohn3, Johannes G Ramaekers2

  • 1Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK.

Journal of Psychopharmacology (Oxford, England)
|July 1, 2023
PubMed
Summary
This summary is machine-generated.

Randomized controlled trials (RCTs) overlook the placebo effect. This study proposes a new framework, inspired by psychedelic science, to integrate non-drug factors for enhanced patient care.

Keywords:
Placeboadditive modelinteractive modelplacebo effectpsychedelicsset and setting

More Related Videos

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.6K
Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
10:51

Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety

Published on: January 20, 2012

21.4K

Related Experiment Videos

Last Updated: Jul 24, 2025

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
08:50

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants

Published on: December 14, 2014

9.3K
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.6K
Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
10:51

Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety

Published on: January 20, 2012

21.4K

Area of Science:

  • Pharmacology
  • Psychiatry
  • Medical Ethics

Background:

  • Randomized controlled trials (RCTs) isolate drug effects but obscure the significant impact of non-pharmacological variables, termed the placebo effect.
  • Empirical evidence indicates that person and context-dependent factors (physical, social, cultural) interact with and shape drug efficacy.
  • Harnessing the placebo effect in clinical practice faces conceptual and ethical challenges.

Purpose of the Study:

  • To propose a novel framework for understanding and integrating non-drug variables into medical practice.
  • To address the limitations of traditional research designs in accounting for the full spectrum of therapeutic influences.
  • To ethically leverage the placebo effect for improved patient outcomes.

Main Methods:

  • The study proposes a new conceptual framework inspired by the 'set and setting' concept from psychedelic science.
  • This framework emphasizes the interactive and synergistic relationship between pharmacological and non-pharmacological factors.
  • It suggests practical approaches for reintegrating non-drug variables into clinical settings.

Main Results:

  • The proposed framework highlights that drug and non-drug variables are not merely additive but interact synergistically.
  • It provides a basis for understanding how context and individual factors modulate treatment outcomes.
  • The approach offers a pathway to more effectively utilize the placebo effect in medicine.

Conclusions:

  • The traditional RCT design limits the appreciation of extra-pharmacological influences on treatment outcomes.
  • A new framework, integrating non-drug variables through a 'set and setting' model, can enhance therapeutic potential.
  • Ethical integration of the placebo effect into the biomedical toolbox can improve clinical care and patient benefits.